E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 11/20/2012 in the Prospect News PIPE Daily.

FluoroPharma completes $1.55 million private placement of its shares

Investors in offering also receive warrants for 1.82 million shares

By Toni Weeks

San Diego, Nov. 20 - FluoroPharma Medical, Inc. announced it settled a $1.55 million private placement of stock on Nov. 19.

The company sold 1,819,118 common shares at about $0.85 apiece, an 18.06% premium to the Nov. 16 closing share price of $0.72.

Investors also received 100% warrant coverage; the warrants are exercisable for one year at $0.90, a 25% premium to the Nov. 16 closing share price.

Proceeds will be used for working capital.

The biopharmaceutical company is based in Boston.

Issuer:FluoroPharma Medical, Inc.
Issue:Common stock
Amount:$1,546,250
Shares:1,819,118
Price:$0.85 (approximate)
Warrants:For 1,819,118 shares
Warrant expiration:One year
Warrant strike price:$0.90
Settlement date:Nov. 19
Stock symbol:OTCBB: FPMI
Stock price:$0.72 at close Nov. 16
Market capitalization:$16.16 million

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.